Annual EBITDA
-$12.62 M
-$3.03 M-31.59%
June 1, 2024
Summary
- As of February 8, 2025, ATHE annual EBITDA is -$12.62 million, with the most recent change of -$3.03 million (-31.59%) on June 1, 2024.
- During the last 3 years, ATHE annual EBITDA has fallen by -$1.67 million (-15.27%).
Performance
ATHE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
N/A
June 1, 2024
Summary
- ATHE quarterly EBITDA is not available.
Performance
ATHE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
N/A
June 1, 2024
Summary
- ATHE TTM EBITDA is not available.
Performance
ATHE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ATHE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.6% | - | - |
| 3 y3 years | -15.3% | - | - |
| 5 y5 years | -41.7% | - | - |
ATHE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.6% | at low | ||||
| 5 y | 5-year | -41.7% | at low | ||||
| alltime | all time | <-9999.0% | at low |
Alterity Therapeutics Limited EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | -$12.62 M(+31.6%) | - | - |
| Jun 2023 | -$9.59 M(-12.3%) | - | - |
| Jun 2022 | -$10.94 M(-0.1%) | - | - |
| Jun 2021 | -$10.95 M(+22.1%) | - | - |
| Jun 2020 | -$8.96 M(+0.7%) | - | - |
| Jun 2019 | -$8.90 M(+47.0%) | - | - |
| Jun 2018 | -$6.06 M(+19.0%) | - | - |
| Jun 2017 | -$5.09 M(-16.0%) | - | - |
| Jun 2016 | -$6.06 M(-29.8%) | - | - |
| Jun 2015 | -$8.64 M(-29.1%) | - | - |
| Jun 2014 | -$12.19 M(+53.2%) | - | - |
| Jun 2013 | -$7.96 M(+48.1%) | - | - |
| Jun 2012 | -$5.37 M(-14.7%) | - | - |
| Jun 2011 | -$6.30 M(+46.6%) | - | - |
| Jun 2010 | -$4.30 M(-30.3%) | - | - |
| Jun 2009 | -$6.16 M(-45.8%) | - | - |
| Jun 2008 | -$11.37 M(+32.3%) | -$12.35 M(<-9900.0%) | -$15.44 M(+23.2%) |
| Mar 2008 | - | $107.40 K(-103.3%) | -$12.53 M(-0.0%) |
| Dec 2007 | - | -$3.30 M(-3167.0%) | -$12.53 M(+3.7%) |
| Sep 2007 | - | $107.70 K(-101.1%) | -$12.08 M(-0.1%) |
| Jun 2007 | -$8.59 M | -$9.45 M(-8985.8%) | -$12.10 M(-1.0%) |
| Mar 2007 | - | $106.30 K(-103.7%) | -$12.22 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | - | -$2.85 M(-3281.1%) | -$12.18 M(+5.7%) |
| Sep 2006 | - | $89.60 K(-100.9%) | -$11.53 M(+0.7%) |
| Jun 2006 | -$9.05 M(-22.4%) | -$9.57 M(-6883.8%) | -$11.45 M(-25.9%) |
| Mar 2006 | - | $141.00 K(-106.4%) | -$15.45 M(+2.3%) |
| Dec 2005 | - | -$2.19 M(-1428.2%) | -$15.10 M(+3.6%) |
| Sep 2005 | - | $165.00 K(-101.2%) | -$14.57 M(+2.3%) |
| Jun 2005 | -$11.67 M(+112.3%) | -$13.57 M(-2840.4%) | -$14.25 M(+72.6%) |
| Mar 2005 | - | $495.10 K(-129.7%) | -$8.26 M(-0.4%) |
| Dec 2004 | - | -$1.67 M(-442.8%) | -$8.29 M(+6.1%) |
| Sep 2004 | - | $485.70 K(-106.4%) | -$7.81 M(-1.5%) |
| Jun 2004 | -$5.50 M(+260.3%) | -$7.57 M(-1739.2%) | -$7.93 M(+131.0%) |
| Mar 2004 | - | $462.00 K(-139.0%) | -$3.43 M(-3.4%) |
| Dec 2003 | - | -$1.19 M(-420.5%) | -$3.55 M(+15.4%) |
| Sep 2003 | - | $369.80 K(-112.0%) | -$3.08 M(-7.2%) |
| Jun 2003 | -$1.53 M(-24.0%) | -$3.08 M(-1004.4%) | -$3.32 M(+1288.2%) |
| Mar 2003 | - | $340.30 K(-147.8%) | -$238.90 K(-58.8%) |
| Dec 2002 | - | -$711.80 K(-636.8%) | -$579.20 K(-536.8%) |
| Sep 2002 | - | $132.60 K | $132.60 K |
| Jun 2002 | -$2.01 M(+100.5%) | - | - |
| Jun 2001 | -$1.00 M(+364.3%) | - | - |
| Jun 2000 | -$215.70 K(<-9900.0%) | - | - |
| Jun 1999 | $0.00(0.0%) | - | - |
| Jun 1998 | $0.00 | - | - |
FAQ
- What is Alterity Therapeutics Limited annual EBITDA?
- What is the all time high annual EBITDA for Alterity Therapeutics Limited?
- What is Alterity Therapeutics Limited annual EBITDA year-on-year change?
- What is the all time high quarterly EBITDA for Alterity Therapeutics Limited?
- What is the all time high TTM EBITDA for Alterity Therapeutics Limited?
What is Alterity Therapeutics Limited annual EBITDA?
The current annual EBITDA of ATHE is -$12.62 M
What is the all time high annual EBITDA for Alterity Therapeutics Limited?
Alterity Therapeutics Limited all-time high annual EBITDA is $0.00
What is Alterity Therapeutics Limited annual EBITDA year-on-year change?
Over the past year, ATHE annual EBITDA has changed by -$3.03 M (-31.59%)
What is the all time high quarterly EBITDA for Alterity Therapeutics Limited?
Alterity Therapeutics Limited all-time high quarterly EBITDA is $495.10 K
What is the all time high TTM EBITDA for Alterity Therapeutics Limited?
Alterity Therapeutics Limited all-time high TTM EBITDA is $132.60 K